tiprankstipranks
Bio-Path Holdings (BPTH)
NASDAQ:BPTH

Bio-Path Holdings (BPTH) Financial Statements

349 Followers

Bio-Path Holdings Financial Overview

Bio-Path Holdings's market cap is currently ―. The company's EPS TTM is $-35.707; its P/E ratio is -0.09; Bio-Path Holdings is scheduled to report earnings on May 16, 2024, and the estimated EPS forecast is $-4.54. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -3.20M$ -4.23M$ -5.27M$ -3.99M$ -3.55M
EBITDA$ -3.15M$ -4.19M$ -5.23M$ -3.93M$ -3.50M
Net Income Common Stockholders$ -3.20M$ -4.23M$ -5.27M$ -3.97M$ -3.54M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.40M$ 3.40M$ 6.70M$ 10.40M$ 13.65M
Total Assets$ 5.02M$ 6.48M$ 11.10M$ 15.97M$ 18.54M
Total Debt$ 141.00K$ 168.00K$ 195.00K$ 221.00K$ 246.00K
Net Debt$ -2.26M$ -3.23M$ -6.50M$ -10.18M$ -13.40M
Total Liabilities$ 2.50M$ 1.48M$ 2.00M$ 1.80M$ 2.34M
Stockholders Equity$ 2.50M$ 5.04M$ 9.11M$ 14.17M$ 16.20M
Cash Flow-
Free Cash Flow$ -21.80M$ -3.29M$ -3.65M$ -5.00M$ -3.37M
Operating Cash Flow$ -21.80M$ -3.29M$ -3.65M$ -5.00M$ -3.37M
Investing Cash Flow----$ 0.00
Financing Cash Flow$ 1.69M--$ 1.73M$ 0.00
Currency in USD

Bio-Path Holdings Earnings and Revenue History

Bio-Path Holdings Debt to Assets

Bio-Path Holdings Cash Flow

Bio-Path Holdings Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis